Malaysian Genomics’ Net Profit Expands On Consolidation Of Interest In Pathology Group, MPath.
ACE Market’s Malaysian Genomics Resource Centre Bhd (Malaysian Genomics) saw its fourth quarter revenue grow 57 percent to RM2.91 million, following its consolidation of its now wholly-owned subsidiary MPath Sdn…